[Long term outcome after pulmonary thromboendarterectomy]

Area of Science:

• Cardiovascular Surgery
• Pulmonary Hypertension Research
• Interventional Cardiology

Context:

• Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe condition characterized by persistent pulmonary artery obstruction.
• Pulmonary thromboendarterectomy (PTE) is a surgical procedure aimed at removing organized blood clots from the pulmonary arteries.
• Long-term outcomes of PTE in CTEPH patients require ongoing evaluation to establish its efficacy.

Purpose:

• To assess the long-term effects of pulmonary thromboendarterectomy (PTE) on survival, cardiac function, and pulmonary hemodynamics in patients diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH).

Summary:

• This study followed 13 patients who underwent PTE for CTEPH for a mean of 40 months.
• Results showed no mortality during follow-up, significant improvements in New York Heart Association (NYHA) functional class, arterial oxygenation (PaO2 and oxygen saturation), and a marked decrease in systolic pulmonary artery pressure (SPAP).
• Preoperative NYHA classes III-IV improved to predominantly class I post-PTE, with SPAP decreasing from 97.1 +/- 22.4 mm Hg to 42.6 +/- 10.7 mm Hg.

Impact:

• PTE demonstrates significant long-term benefits for CTEPH patients, enhancing survival rates and improving overall quality of life.
• The procedure leads to substantial improvements in cardiac function and pulmonary hemodynamics, as evidenced by enhanced oxygenation and reduced pulmonary artery pressures.
• These findings support PTE as a crucial therapeutic option for managing chronic thromboembolic pulmonary hypertension.